Eli Lilly and Company
COMPOUNDS AND METHODS TARGETING INTERLEUKIN-34
Last updated:
Abstract:
The present invention relates to IL-34 antibodies, compositions comprising the same, and methods of using the antibodies and or compositions thereof for treating immune-mediated diseases such as neurodegenerative diseases, for example Alzheimer's Disease or a tauopathy disease.
Status:
Application
Type:
Utility
Filling date:
23 Apr 2021
Issue date:
25 Nov 2021